AstraZeneca’s drug to treat rare blood vessel disease gets EU nod
AstraZeneca Plc’s drug Fasenra got approval from the European Union regulator for treating adult patients with a rare inflammation of blood vessels.
Drugs
Health
Pharma
Drugs
Pharma
Israeli firm Teva Pharmaceuticals under EC scanner
The EC has intimated Teva Pharmaceutical Industries, an Israel-based global company, of its "preliminary view" that it has breached EU antitrust rules by.